Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Search Results

Your search returned 1870 record(s).

Page 111 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:

  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1101 10.7 months Advanced hepatocellular carcinoma 3 Chemotherapy
The University of Texas M.D. Anderson Cancer Center United States 9/2007
Treatment Details: Patients: This phase II study involved 40 patients with advanced, unresectable hepatocellular carcinoma (liver cancer). The median age was 64 years, ranging from 33 to 83. The majority (8
1102 10.7 months Metastatic colorectal cancer 4 Biologic therapy
University General Hospital of Heraklion Greece 11/2006
Treatment Details: Patients: This phase II study involved 40 patients with metastatic colorectal cancer. There were 23 men and 17 women. The median age was 65, ranging from 35-84 years. All had previously
1103 10.7 months GBM 2 Immunotherapy
Ibaraki Prefectural Central Hospital Japan 8/2007
Treatment Details: Patients: This study involved 12 patients with WHO grade IV glioblastoma multiforme. The average age was 50.5 years, ranging from 35-63. Eight of the patients had recurrent disease. Tr
1104 10.7 months Ovarian cancer or peritoneal serous cancer 5 Biologic therapy
Beth Israel Deaconess Medical Center United States 11/2007
Treatment Details: Patients: This phase II study involved 44 women with platinum resistant ovarian cancer (36 patients) or peritoneal serous cancer (8 patients). The median age of the patients was 59.5, rangi
1105 10.7 months Advanced hepatocellular carcinoma 4 Biologic therapy
Centro de Investigaciones en Red de Enfermedades Hepáticas y Digestivas Hospital Clínic Barcelona Spain 7/2008
Treatment Details: Patients: This phase 3 study involved 602 patients with advanced hepatocellular carcinoma (liver cancer). The majority of patients (87%) were men. Treatment: Patients were treated with
1106 10.7 months Metastatic colorectal cancer 5 Biologic therapy
Ospedale San Martino Italy 5/2008
Treatment Details: Patients: This phase III study involved 1,298 patients with metastatic colorectal cancer. The median age was 62, ranging from 21 to 90 years of age. Almost 63% of these patients were men.
1107 10.7 months Advanced NSCLC 5 Chemotherapy
The Sarah Cannon Cancer Center and Tennessee Oncology United States 9/2002
Treatment Details: Patients: This Phase II study involved a total of 267 patients with advanced (Stage IIIB and IV) non-small-cell lung carcinoma. Patients were divided into 4 groups: Group A contained 71 pat
1108 10.6 months Advanced NSCLC 3 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 9/2005
Treatment Details: Patients: This Phase III study involved 1059 patients with advanced (stage IIIB/IV) non-small-cell lung cancer. None of the patients had been treated. The patients were randomly assigned i
1109 10.6 months Malignant Pleural Mesothelioma 4 Chemotherapy
St Bartholomew's Hospital United Kingdom 12/2000
Treatment Details: Patients: This Phase II study involved 29 patients with malignant pleural mesothelioma. Treatment: The treatment consisted of administration of the chemotherapy drug, vinorelbine (navelbi
1110 10.6 months Metastatic melanoma 4 Chemotherapy
University of Sydney at Westmead Hospital Australia 3/2010
Treatment Details: Patients: This study involved patients with metastatic melanoma who had not received prior chemotherapy. Patients were separated into two separate treatment groups. Group A had 40 patient
Page 111 of 187  | Previous Page  | Next Page